AbbVie (ABBV) FY2021 results: revenue $56.2 billion, up 22.7% on the year
AbbVie Inc. (ABBV) reported revenue of $56.2 billion for fiscal 2021, the year ended 31 December 2021, up 22.7% on the year before. Net income was $11.5 billion, up 150.0%, and diluted earnings per share $6.45. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2022.
Revenue
$56.2 billion
+22.7% on the year
FY2014FY2021
Operating margin
31.9%
24.8% a year earlier
FY2014FY2021
Net income
$11.5 billion
+150.0% on the year
FY2014FY2021
Diluted EPS
$6.45
+137.1% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
22,777
17,588
13,324
+29.5%
Capital expenditure
787
798
552
-1.4%
Free cash flow
21,990
16,790
12,772
+31.0%
Free cash flow margin
39.1%
36.7%
38.4%
Cash from investing
-2,344
-37,557
596
Cash from financing
-19,039
-11,501
18,708
Depreciation and amortisation
8,521
6,471
2,017
+31.7%
Share-based compensation
692
753
430
-8.1%
Buybacks
934
978
629
-4.5%
Dividends paid
9,261
7,716
6,366
+20.0%
Dividend per share
$5.31
$4.84
$4.39
+9.7%
Diluted shares, weighted
1,777m
1,673m
1,484m
+6.2%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
15,408
13,076
-8,172
+17.8%
Non-controlling interest
28.0
21.0
0.0
+33.3%
Short-term borrowings
n/a
n/a
0.0
Debt
76,684
86,056
67,233
-10.9%
Operating lease liabilities
713
832
n/a
-14.3%
Finance lease liabilities
25.0
21.0
n/a
+19.0%
Other liabilities
53,671
50,559
30,054
+6.2%
Total liabilities and equity
146,529
150,565
89,115
-2.7%
Fixed assets
5,110
5,248
2,962
-2.6%
Goodwill
32,379
33,124
15,604
-2.2%
Intangible assets
75,951
82,876
18,649
-8.4%
Investments
361
323
93.0
+11.8%
Cash and equivalents
9,746
8,449
39,924
+15.4%
Receivables
9,977
8,822
5,428
+13.1%
Inventory
3,128
3,310
1,813
-5.5%
Other assets
9,877
8,413
4,642
+17.4%
Total assets
146,529
150,565
89,115
-2.7%
10-K for the year ended 31 December 2021, filed 18 February 2022: the filing.